Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 avr. 2014 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Initiates Phase 3 Clinical Trial of EVK-001 for Treatment of Gastroparesis

SOLANA BEACH, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
25 mars 2014 16h05 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Fourth Quarter and Year End 2013 Results

SOLANA BEACH, Calif., March 25, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
10 mars 2014 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter 2013 Financial Results

SAN DIEGO, March 10, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it...
04 mars 2014 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at 26th Annual ROTH Conference

SAN DIEGO, March 4, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that its...
22 janv. 2014 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Study Reports Positive Results of Metoclopramide Nasal Spray for Gastroparesis in Diabetics

SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the...
07 janv. 2014 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at Biotech Showcase(TM) 2014

SAN DIEGO, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that its...
02 déc. 2013 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations

SAN DIEGO, Dec. 2, 2013 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, announced today the...
26 nov. 2013 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis

SAN DIEGO, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the...
13 nov. 2013 16h01 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Third Quarter 2013 Results

SAN DIEGO, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its...
05 nov. 2013 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2013 Financial Results

SAN DIEGO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it will...

Page précédente